Neurovivas Tablet (Naftopidil)
Naftopidil
Prescription medication
Anguk Newpharm Co., Ltd.
MFDS item code 201801458 · Approved 2018.04.02
This product's status changed to Expired on 2023.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of voiding dysfunction caused by benign prostatic hyperplasia
This medication is used to alleviate urinary disturbances caused by benign prostatic hyperplasia.
In adults, start with naftopidil 25mg once daily. If the effect is insufficient, gradually increase the dose to 50~75mg at intervals of 1~2 weeks, and administer orally once daily after a meal. The dose may be adjusted according to symptoms; however, the maximum daily dose is 75mg.
This medicine should not be used in patients who have had an allergic reaction to its components. Patients with liver function issues may experience increased blood concentration of this medication, hence caution is advised. Patients with severe heart disease or severe cerebrovascular disorders should be administered this drug with care due to limited experience with its use. Elderly patients may have reduced liver function, which can lead to prolonged elevation of blood concentration, and therefore care should be taken. Patients taking PDE5 inhibitors that cause vasodilation should be aware that using this drug together may lead to a risk of excessively low blood pressure. Patients with orthostatic hypotension may have exacerbation of symptoms when taking this medication, hence caution is recommended. Overdosing this medication can result in overly low blood pressure, so the prescribed dosage must be strictly followed. Dizziness or vertigo can occur early in treatment, so extra caution is advised when working at heights or driving. If taking blood pressure-lowering medications concurrently, blood pressure changes should be closely monitored, and dosage adjustments may be necessary if blood pressure becomes too low. This medication is a treatment for symptom relief and does not address the underlying cause, so alternative treatments should be considered if it fails to work effectively. If serious adverse effects such as liver dysfunction, jaundice, or loss of consciousness occur, medication should be stopped immediately, and medical attention should be sought. Keep out of reach of children, and when taking the medication, it should be removed from the packaging and swallowed directly. Elderly individuals should be monitored carefully while using this medication due to the possibility of reduced liver function.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container that does not allow light and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication.
White circular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Naftopidil
Prescription medication
Anguk Newpharm Co., Ltd.

Naftopidil 25mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Naftopidil 75mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Naftopidil 50mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Naftopidil 75mg
Tablet · Prescription medication
Dongku Bio Pharmaceutical Co., Ltd.

Naftopidil 75mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Naftopidil 75mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Naftopidil 75mg
Tablet · Prescription medication
Genupharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.